ACCURAY INC
ARAYNasdaq
$0.26
↓ -2.3%Jul 17 close · end-of-day
Price
1Y↓ -80.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
—
Enterprise Value
—
P/E
—
P/S
—
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$428.6M
Net Income (TTM)
-$46.1M
Free Cash Flow (TTM)
-$25.8M
Gross Margin
26.8%
Operating Margin
-6.5%
Net Margin
-10.8%
ROE
-110.6%
ROIC
-14.7%
Debt / Equity
3.5
Net Cash
-$107.1M
Return 1Y
-80.9%
Company profile
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. The company also provides the TomoTherapy System, including the Radixact System.
- CEO
- Suzanne C. Winter
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 1,040
- Headquarters
- Wisconsin
- Website
- accuray.com
Management & directors
- Chalke SandeepSVP, Chief Commercial Officer
- Peralta LeonelSVP, Chief Operations Officer
- Pervaiz AliSVP Chief Financial Officer
- La Neve Stephen R.CEO
- Murphy Michael JohnVP, Corporate Controller
- Winter Suzanne CPresident and CEO
Roles derived from SEC Form 4 filings.
Earnings
ARAY Q3 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$104.8M↓ -7.4%
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $396.3M | $429.9M | $447.6M | $446.6M | $458.5M |
| Gross profit | $159.5M | $160.0M | $154.0M | $142.9M | $147.0M |
| Operating income | $22.2M | $8.1M | $2.4M | $504,000.00 | $7.8M |
| Net income | -$6.3M | -$5.3M | -$9.3M | -$15.5M | -$1.6M |
| Diluted EPS | -$0.07 | -$0.06 | -$0.10 | -$0.16 | -$0.02 |
| Operating cash flow | $38.5M | -$2.4M | $15.5M | -$11.9M | $2.9M |
| Free cash flow | $36.2M | -$7.1M | $2.9M | -$15.5M | -$1.4M |
| Gross margin | 40.3% | 37.2% | 34.4% | 32.0% | 32.1% |
| Operating margin | 5.6% | 1.9% | 0.5% | 0.1% | 1.7% |
| Net margin | -1.6% | -1.2% | -2.1% | -3.5% | -0.3% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $134.3M | $101.5M | $116.2M | $113.2M | $127.5M | $93.9M | $102.2M | $104.8M |
| Gross profit | $38.5M | $34.5M | $41.9M | $31.6M | $39.0M | $26.5M | $24.1M | $25.3M |
| Operating income | $6.8M | -$2.1M | $4.7M | $1.0M | $4.2M | -$11.3M | -$11.6M | -$9.1M |
| Net income | $3.4M | -$4.0M | $2.5M | -$1.3M | $1.1M | -$21.7M | -$13.8M | -$11.8M |
| Diluted EPS | $0.03 | -$0.04 | $0.02 | -$0.01 | $0.01 | -$0.18 | -$0.11 | — |
| Operating cash flow | $9.9M | -$7.3M | $1.8M | $18.1M | -$9.7M | $12.2M | -$16.0M | -$5.6M |
| Free cash flow | $9.4M | -$8.4M | $927,000.00 | $17.1M | -$11.0M | $10.3M | -$19.0M | -$6.1M |
| Gross margin | 28.6% | 33.9% | 36.1% | 27.9% | 30.6% | 28.3% | 23.5% | 24.1% |
| Operating margin | 5.1% | -2.1% | 4.1% | 0.9% | 3.3% | -12.0% | -11.3% | -8.7% |
| Net margin | 2.5% | -3.9% | 2.2% | -1.1% | 0.9% | -23.1% | -13.5% | -11.3% |
Company news
May 29, 2026
May 12, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-31 | Chalke Sandeep· SVP, Chief Commercial Officer | Tax withholding | 40,000 | $0.39 | $15,524.00 | filing |
| 2026-02-28 | Peralta Leonel· SVP, Chief Operations Officer | Tax withholding | 28,969 | $0.55 | $15,932.95 | filing |
| 2026-02-28 | Peralta Leonel· SVP, Chief Operations Officer | Option exercise | 83,723 | $0.00 | $0.00 | filing |
| 2026-02-20 | MAYER STEVEN F | Buy | 54,875 | $0.56 | $30,878.16 | filing |
| 2026-02-19 | MAYER STEVEN F | Buy | 69,000 | $0.53 | $36,597.60 | filing |
| 2026-02-18 | MAYER STEVEN F | Buy | 126,125 | $0.53 | $67,199.40 | filing |
| 2025-12-31 | Scott Byron C | Tax withholding | 3,774 | $0.82 | $3,112.04 | filing |
| 2025-12-31 | Scott Byron C | Option exercise | 9,433 | $0.00 | $0.00 | filing |
| 2025-12-01 | Chalke Sandeep· SVP, Chief Commercial Officer | Tax withholding | 64,477 | $1.02 | $65,766.54 | filing |
| 2025-12-01 | Pervaiz Ali· SVP Chief Financial Officer | Tax withholding | 57,341 | $1.02 | $58,487.82 | filing |
| 2025-11-29 | Chalke Sandeep· SVP, Chief Commercial Officer | Option exercise | 50,314 | $0.00 | $0.00 | filing |
| 2025-11-29 | Pervaiz Ali· SVP Chief Financial Officer | Option exercise | 44,025 | $0.00 | $0.00 | filing |
| 2025-11-28 | Galbato Chan | Award | 50,000 | $0.00 | $0.00 | filing |
| 2025-11-28 | MAYER STEVEN F | Award | 895,391 | $0.00 | $0.00 | filing |
| 2025-11-21 | Scott Byron C | Tax withholding | 22,642 | $1.05 | $23,774.10 | filing |
| 2025-11-21 | Scott Byron C | Tax withholding | 22,642 | $1.05 | $23,774.10 | filing |
| 2025-11-21 | HUSS BEVERLY A | Tax withholding | 22,642 | $1.05 | $23,774.10 | filing |
| 2025-11-21 | HUSS BEVERLY A | Tax withholding | 22,642 | $1.05 | $23,774.10 | filing |
| 2025-11-21 | Hindman James M. | Option exercise | 56,603 | $0.00 | $0.00 | filing |
| 2025-11-21 | WHITTERS JOSEPH E | Option exercise | 56,603 | $0.00 | $0.00 | filing |
| 2025-11-21 | WHITTERS JOSEPH E | Option exercise | 56,603 | $0.00 | $0.00 | filing |
| 2025-11-21 | Scott Byron C | Option exercise | 56,603 | $0.00 | $0.00 | filing |
| 2025-11-21 | Scott Byron C | Option exercise | 56,603 | $0.00 | $0.00 | filing |
| 2025-11-21 | Nishimura Mika | Option exercise | 56,603 | $0.00 | $0.00 | filing |
| 2025-11-21 | Nishimura Mika | Option exercise | 56,603 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.